The Soluble Guanylyl Cyclase Activator Bay 58-2667 Selectively Limits Cardiomyocyte Hypertrophy
出版年份 2012 全文链接
标题
The Soluble Guanylyl Cyclase Activator Bay 58-2667 Selectively Limits Cardiomyocyte Hypertrophy
作者
关键词
Fibroblasts, Superoxides, DNA synthesis, Protein synthesis, cGMP signaling, Fibrosis, Hemodynamics, Muscle cells
出版物
PLoS One
Volume 7, Issue 11, Pages e44481
出版商
Public Library of Science (PLoS)
发表日期
2012-11-08
DOI
10.1371/journal.pone.0044481
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- cGMP becomes a drug target
- (2012) Jens Schlossmann et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Nitroxyl (HNO) Stimulates Soluble Guanylyl Cyclase to Suppress Cardiomyocyte Hypertrophy and Superoxide Generation
- (2012) Eliane Q. Lin et al. PLoS One
- Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
- (2011) Johannes-Peter Stasch et al. CIRCULATION
- Soluble Guanylate Cyclase Stimulation Prevents Fibrotic Tissue Remodeling and Improves Survival in Salt-Sensitive Dahl Rats
- (2011) Sandra Geschka et al. PLoS One
- Expression and functional roles of guanylate cyclase isoforms in BRIN-BD11 β-cells
- (2011) Mark A. Russell et al. Islets
- The anti-aggregating effect of BAY 41-2272, a stimulator of soluble guanylyl cyclase, requires the presence of nitric oxide
- (2010) Séverine Roger et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle
- (2010) Haroldo A. Toque et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- BAY 41-2272 inhibits the development of chronic hypoxic pulmonary hypertension in rats
- (2010) Lise Bech Thorsen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Anti-aggregating effect of BAY 58-2667, an activator of soluble guanylyl cyclase
- (2010) Séverine Roger et al. VASCULAR PHARMACOLOGY
- Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart
- (2009) Juliano L. Sartoretto et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus
- (2009) Marc Chester et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation
- (2009) LS Hoffmann et al. BRITISH JOURNAL OF PHARMACOLOGY
- B-Type Natriuretic Peptide: Endogenous Regulator of Myocardial Structure, Biomarker and Therapeutic Target
- (2009) Rebecca Ritchie et al. CURRENT MOLECULAR MEDICINE
- BAY 58-2667, a nitric oxide-independent guanylyl cyclase activator, pharmacologically post-conditions rabbit and rat hearts
- (2009) T. Krieg et al. EUROPEAN HEART JOURNAL
- Pressure-independent effects of pharmacological stimulation of soluble guanylate cyclase on fibrosis in pressure-overloaded rat heart
- (2009) Hiroyuki Masuyama et al. HYPERTENSION RESEARCH
- Exploiting cGMP-based therapies for the prevention of left ventricular hypertrophy: NO• and beyond
- (2009) Rebecca H. Ritchie et al. PHARMACOLOGY & THERAPEUTICS
- Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics
- (2009) Emily J. Tsai et al. PHARMACOLOGY & THERAPEUTICS
- Probing the presence of the ligand-binding haem in cellular nitric oxide receptors
- (2008) B Roy et al. BRITISH JOURNAL OF PHARMACOLOGY
- NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5/6 nephrectomy
- (2006) Philipp Kalk et al. BRITISH JOURNAL OF PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started